Masimo Joins Forces with the Mobilize Recovery 2024 Bus Tour
Collaborative Partnership Designed to Enhance Nationwide Efforts to Combat the Opioid Epidemic and Improve Addiction RecoveryIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI),...
Month: June 2024
KindlyMD Becomes First Utah Alternative Medical Treatment Company to Contract Under State’s Top Insurance Payors
Insurance payors include Medicare, Utah's largest insurer, Select Health, and Medicaid, providing KindlyMD nearly 70% statewide comprehensive insurance coverage SALT...
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform
Patent covers the Composition of the Company's Proprietary Linea™ RNAP, a Core Technology Empowering the Linea™ IVT PlatformPatent Application Also...
Inspire Names Health Tech Leader Brett Kleger as New CEO
ARLINGTON, VA / ACCESSWIRE / June 5, 2024 / Inspire, the world's leading online health community and real-world data platform,...
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
REDWOOD CITY, CA / ACCESSWIRE / June 5, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and...
How Focused Giving Can Unlock Billions and Catapult Women’s Wealth
NORTHAMPTON, MA / ACCESSWIRE / June 5, 2024 / CAREBy Mark MuckerheideOriginally published on World Economic Forum.I'll start with a...
1933 Industries Extends Expiry Date of Warrants
VANCOUVER, BC / ACCESSWIRE / June 5, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused...
Rett Syndrome Research Trust Launches Roadmap to Cures to Advance Next-Generation Genetic Medicines into Clinical Trials
Roadmap to Cures is an initiative that seeks to raise $40M over the next four years to advance genetic medicine...
Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
Financing led by Zimmer Biomet with participation from existing investors Johnson & Johnson Innovation – JJDC, Inc., Gideon Strategic Partners,...
CirrusMD Completes National Roll-out of VA Health Chat, Providing Care Access for over 6.8 Million Veterans
VA Health Chat is now available to Veterans in all 18 VISNs across the U.S.DENVER, June 05, 2024 (GLOBE NEWSWIRE)...
Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical...
Safety Shot Partners with Prime CSB to Expand Distribution Into New York and New Jersey
The First of Its Kind Beverage Adds Two Key Markets to Distribution as Part of Its Northeast Expansion Plan JUPITER,...
First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
DNA vaccine proof-of-concept study expected to demonstrate an “mRNA better” platform LAWRENCEVILLE, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- IMUNON,...
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
FDA review of historic data shows patients who received robotic prostatectomies have overall cancer survival rates on par with open...
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
Highly accurate continuous blood glucose monitor demonstrates Mean Absolute Relative Difference (MARD) of 4.7% at Day 90 Continuous blood glucose...
Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit
InjectEZ acquisition establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. has progressed with the payment of...
Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Study intended to optimize design elements needed for the upcoming US Pivotal Phase 3 studiesand support ongoing partnership discussions Topline...
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE...
Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform
Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service New AI capabilities available to patients who submit...
Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts
Appoints David Sutherland, CPA, as Vice President of Finance and ControllerBOSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Carrick Therapeutics Inc.,...